Although an uncommon malignancy, carcinoma of the gallbladder is the fifth most common cancer of the gastrointestinal tract and the most common cancer of the biliary tract [1]. The diagnosis of gallbladder carcinoma is made incidentally at the time of exploration in 1% of patients undergoing surgical treatment for cholelithiasis [1,2]. Carcinoma of the gallbladder is more common in females, three fourths of the patients being women with a median age in the seventh decade. In most patients, the disease is advanced and unresectable. The overall prognosis, therefore, is rather dismal, with 5year survival rates of less than 5% reported in most large published series [1–27]. However, in a small group of early lesions, surgery provides a reasonable probability of long-term survival. Radiation and chemotherapy have mostly a palliative role in the treatment of gallbladder carcinoma, and the experience with these treatment modalities is derived from their use in a rather limited number of patients.